- Home
- CDIO vs ADIL Comparison
CDIO vs ADIL Comparison
Compare CDIO & ADIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDIO
- ADIL
- Stock Information
- Founded
- CDIO 2017
- ADIL 2010
- Country
- CDIO United States
- ADIL United States
- Employees
- CDIO N/A
- ADIL N/A
- Industry
- CDIO Biotechnology: Commercial Physical & Biological Resarch
- ADIL Biotechnology: Pharmaceutical Preparations
- Sector
- CDIO Health Care
- ADIL Health Care
- Exchange
- CDIO Nasdaq
- ADIL Nasdaq
- Market Cap
- CDIO 6.4M
- ADIL 7.6M
- IPO Year
- CDIO N/A
- ADIL 2018
- Fundamental
- Price
- CDIO $3.86
- ADIL $0.35
- Analyst Decision
- CDIO
- ADIL Strong Buy
- Analyst Count
- CDIO 0
- ADIL 1
- Target Price
- CDIO N/A
- ADIL $8.00
- AVG Volume (30 Days)
- CDIO 21.5K
- ADIL 545.0K
- Earning Date
- CDIO 11-12-2025
- ADIL 11-12-2025
- Dividend Yield
- CDIO N/A
- ADIL N/A
- EPS Growth
- CDIO N/A
- ADIL N/A
- EPS
- CDIO N/A
- ADIL N/A
- Revenue
- CDIO $19,507.00
- ADIL N/A
- Revenue This Year
- CDIO $1,434.82
- ADIL N/A
- Revenue Next Year
- CDIO $4,661.91
- ADIL N/A
- P/E Ratio
- CDIO N/A
- ADIL N/A
- Revenue Growth
- CDIO N/A
- ADIL N/A
- 52 Week Low
- CDIO $3.22
- ADIL $0.22
- 52 Week High
- CDIO $53.10
- ADIL $1.30
- Technical
- Relative Strength Index (RSI)
- CDIO 51.46
- ADIL 36.44
- Support Level
- CDIO $3.58
- ADIL $0.34
- Resistance Level
- CDIO $3.98
- ADIL $0.38
- Average True Range (ATR)
- CDIO 0.23
- ADIL 0.02
- MACD
- CDIO 0.03
- ADIL 0.00
- Stochastic Oscillator
- CDIO 66.67
- ADIL 8.50
About CDIO Cardio Diagnostics Holdings Inc. Common stock
Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases. The company offers three AI-powered solutions for the risk assessment, detection, management, and monitoring of coronary heart diseases. These solutions are Epi+Gen CHD, a symptomatic CHD risk assessment clinical blood test targeting CHD events; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform coupled to the Epi+Gen CHD and PrecisionCHD tests that provide personalized insights by linking the epigenetic and genetic biomarkers evaluated by these tests to the drivers of coronary heart disease.
About ADIL Adial Pharmaceuticals Inc
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. The active ingredient in AD04 is ondansetron, a serotonin-3 antagonist.